JPS5353628A - Nnacetyllmuramyllllalanylldd isogultamine ppaminophenyl derivatives* and immunological adjant containing said compound and process for preparation thereof - Google Patents

Nnacetyllmuramyllllalanylldd isogultamine ppaminophenyl derivatives* and immunological adjant containing said compound and process for preparation thereof

Info

Publication number
JPS5353628A
JPS5353628A JP12588277A JP12588277A JPS5353628A JP S5353628 A JPS5353628 A JP S5353628A JP 12588277 A JP12588277 A JP 12588277A JP 12588277 A JP12588277 A JP 12588277A JP S5353628 A JPS5353628 A JP S5353628A
Authority
JP
Japan
Prior art keywords
ppaminophenyl
nnacetyllmuramyllllalanylldd
isogultamine
adjant
immunological
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP12588277A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6126800B2 (enExample
Inventor
Derien Maruseru
Rudoure Edogiyaaru
Odeibeeru Furansowaazu
Shiedeidou Rui
Shiyoai Jiyan
Rufuranshie Pieeru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bpifrance Financement SA
Original Assignee
Agence National de Valorisation de la Recherche ANVAR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agence National de Valorisation de la Recherche ANVAR filed Critical Agence National de Valorisation de la Recherche ANVAR
Publication of JPS5353628A publication Critical patent/JPS5353628A/ja
Publication of JPS6126800B2 publication Critical patent/JPS6126800B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/5555—Muramyl dipeptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
JP12588277A 1976-10-22 1977-10-21 Nnacetyllmuramyllllalanylldd isogultamine ppaminophenyl derivatives* and immunological adjant containing said compound and process for preparation thereof Granted JPS5353628A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7631935A FR2368282A1 (fr) 1976-10-22 1976-10-22 Adjuvant immunologique constitue par le p-amino-phenyl de n-acetyl-muramyl-l-alanyl-d-isoglutamine

Publications (2)

Publication Number Publication Date
JPS5353628A true JPS5353628A (en) 1978-05-16
JPS6126800B2 JPS6126800B2 (enExample) 1986-06-21

Family

ID=9179110

Family Applications (1)

Application Number Title Priority Date Filing Date
JP12588277A Granted JPS5353628A (en) 1976-10-22 1977-10-21 Nnacetyllmuramyllllalanylldd isogultamine ppaminophenyl derivatives* and immunological adjant containing said compound and process for preparation thereof

Country Status (6)

Country Link
US (1) US4185089A (enExample)
JP (1) JPS5353628A (enExample)
CH (1) CH626629A5 (enExample)
DE (1) DE2747379A1 (enExample)
FR (1) FR2368282A1 (enExample)
GB (1) GB1590659A (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2428051A1 (fr) * 1978-06-05 1980-01-04 Anvar Nouveaux composes du type muramyl-peptide et medicaments les contenant
US4377570A (en) * 1979-01-29 1983-03-22 Merck & Co., Inc. Immunologically active dipeptidyl saccharides and methods of preparation
FR2449697A1 (fr) 1979-02-20 1980-09-19 Anvar Nouveaux muramyl-peptides substitues sur un azote peptidique et medicaments les contenant
FI75578C (fi) * 1979-07-25 1988-07-11 Ciba Geigy Ag Analogifoerfarande foer framstaellning av farmakologiskt verkande lipofila fosfatidylmuramylpeptider.
US4933179A (en) * 1983-08-22 1990-06-12 Syntex (U.S.A.) Inc. Feline leukemia virus antigen vaccines
US4772466A (en) * 1983-08-22 1988-09-20 Syntex (U.S.A.) Inc. Vaccines comprising polyoxypropylene-polyoxyethylene block polymer based adjuvants
US4606918A (en) * 1983-08-22 1986-08-19 Syntex (U.S.A.) Inc. Polyoxypropylene-polyoxyethylene block polymer based adjuvants
US4770874A (en) * 1983-08-22 1988-09-13 Syntex (U.S.A.) Inc. Polyoxypropylene-polyoxyethylene block polymer based adjuvants
US5554372A (en) * 1986-09-22 1996-09-10 Emory University Methods and vaccines comprising surface-active copolymers
US5149529A (en) * 1988-04-08 1992-09-22 Board Of Trustees Of Leland Chiron Corporation Compositions and treatment for herpes simplex
US5416070A (en) * 1988-07-08 1995-05-16 Immunotherapeutics, Inc. Composition for macrophage activation
US4950645A (en) * 1988-07-08 1990-08-21 Immunotherapeutics, Inc. Composition for macrophage activation
US6156319A (en) * 1994-07-25 2000-12-05 The Trustees Of The University Of Pennsylvania Soluble herpesvirus glycoprotein complex vaccine
RU2083588C1 (ru) * 1995-09-11 1997-07-10 Безруков Михаил Васильевич Способ получения мурамилпептидов
AUPR079700A0 (en) * 2000-10-17 2000-11-09 Alchemia Pty Ltd Combinatorial libraries of monosaccharides
WO2005013918A2 (en) 2003-02-28 2005-02-17 The Trustees Of The University Of Pennsylvania Compositions, methods and kits relating to poxvirus subunit vaccines
JP2008522951A (ja) * 2004-07-19 2008-07-03 ベイラー・カレツジ・オブ・メデイシン サイトカインシグナル伝達調節物質の調節および免疫療法のための応用
KR101203401B1 (ko) * 2005-06-08 2012-11-22 이쉥 바이오파마(싱가포르)피티이 리미티드 폴리이노신산-폴리시티딜산-기초 보조제
CN101501055B (zh) * 2005-06-23 2016-05-11 贝勒医学院 负性免疫调节因子的调节和免疫疗法应用
US20070166800A1 (en) * 2006-01-13 2007-07-19 Haixiang Lin Immunogenic substances comprising a polyinosinic acid-polycytidilic acid based adjuvant
US20070166239A1 (en) * 2006-01-13 2007-07-19 Haixiang Lin Mucosal immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant
WO2008116347A1 (en) 2007-03-26 2008-10-02 General Regeneratives Limited Methods for promoting protection and regeneration of bone marrow using cxcl9 and anti-cxcl9 antibodies
EP2222344A4 (en) * 2007-11-30 2012-11-07 Baylor College Medicine VACCINATE COMPOSITIONS WITH DENDRITIC CELLS AND THEIR USE
US9808504B2 (en) 2009-09-22 2017-11-07 Yale University Immunogenic epitopes as targets for universal cancer vaccines
CN104203287B (zh) 2011-07-12 2017-07-14 费城健康及教育公司,d/b/a,德雷克塞尔大学医学院 新型艰难梭菌dna疫苗
EP2951199A4 (en) 2013-01-31 2016-07-20 Univ Jefferson Fusion proteins for the modulation of regulatory and effector T cells
WO2015116178A1 (en) 2014-01-31 2015-08-06 Thomas Jefferson University Fusion proteins for modulating regulatory and effector t cells
WO2016105274A1 (en) 2014-12-23 2016-06-30 Yisheng Biopharma (Singapore) Pte Ltd A rabies composition comprising pika adjuvant
WO2016138286A1 (en) 2015-02-26 2016-09-01 Stc.Unm Irgm and precision autophagy controls for antimicrobial and inflammatory disease states and methods of detection of autophagy
WO2020140007A1 (en) 2018-12-28 2020-07-02 University Of Rochester Gene therapy for best1 dominant mutations
KR20260104103A (ko) 2023-10-31 2026-07-03 무스크 파운데이션 포 리서치 디벨롭먼트 섬유증 치료를 위한 에놀라제 억제제 pomhex의 용도
WO2026015821A1 (en) 2024-07-12 2026-01-15 University Of Rochester Antibiotic alkaloid and methods of generating and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4082736A (en) * 1976-04-26 1978-04-04 Syntex (U.S.A.) Inc. Novel immunological adjuvant compounds and methods of preparation thereof
US4082735A (en) * 1976-04-26 1978-04-04 Syntex (U.S.A.) Inc. Novel immunological adjuvant compounds and methods of preparation thereof

Also Published As

Publication number Publication date
US4185089A (en) 1980-01-22
FR2368282B1 (enExample) 1980-10-17
GB1590659A (en) 1981-06-03
FR2368282A1 (fr) 1978-05-19
JPS6126800B2 (enExample) 1986-06-21
DE2747379A1 (de) 1978-04-27
CH626629A5 (enExample) 1981-11-30

Similar Documents

Publication Publication Date Title
IL60589A0 (en) Norpinanone compounds and process for their preparation
JPS5321134A (en) 44hydroxyphenylalkanolamine derivatives and process for preparation therefor
IL52749A0 (en) Process for the preparation of m-phenoxybenzaldehyde
GB1523529A (en) Process for the preparation of tetrazole - 5 - carboxamides
PT66694A (en) Process for the preparation of gamma-pyrones
GR63697B (en) Process for derivatives preparation of phenyl-alamine
PH12481A (en) Process for preparation of 3-halomethylcephens
GB1534213A (en) Process for the preparation of basically-substituted phenyl-acetonitriles
GR62474B (en) Process for the preparation of novel compounds of ergolene and ergoline structure
GR63658B (en) Process for derivatives preparation of naphyridine
CH609341A5 (en) Process for the preparation of 5-methylisoxazole- 4-carboxanilides
GB1552402A (en) Process for the preparation of 3-deoxyanthocyanidins
IL52488A (en) 9-desacetyl daunoruiin derivatives and process for their preparation
JPS52128391A (en) Bisspenicillanoyloxyyalkane compound and process for preparing same
JPS52131598A (en) Prganic compound and process for preparing same
GB1549547A (en) Process for the preparation of 4-phenoxy-phenols
GB1519931A (en) Process for the preparation of ethyl aminocyanoacetate
PT66889B (en) Process for the preparation of derivatives of the d-threo-1-phenyl
IL51433A0 (en) Process for preparation of 7-alkoxy-3-chloromethylcephems
ZA767468B (en) Process for the preparation of 2-aminoindante derivatives
IL51653A0 (en) Process for preparation of 3-hydroxymethylcephems
PT67266B (en) Process for the preparation of new phenilformamidine derivatives
IL51271A (en) Process for the preparation of 0-dialkyl-aminomethylphenols
CS180986B1 (en) Process for the preparation of dimethylterphtalate
KR780000711B1 (en) Process for preparation of l-4-hydroxyphenylclycine